The role of nuclear factor-κB in interleukin-8 expression by human adenoidal fibroblasts

Laryngoscope

Volumn 113, Issue 8, 2003, Pages 1378-1385

  Takaki, Minoru ^b   Ushikai, Masoto ^b   Deguchi, Kohji ^b   Nishimoto, Kengo ^b   Matsune, Shoji ^b   Kurono, Yuichi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b NONE

Author keywords

Adenoid; Clarithromycin; Fibroblast; Interleukin 8; Nuclear factor B

Indexed keywords

CLARITHROMYCIN; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; TOSYLPHENYLALANYL CHLOROMETHYL KETONE;

ADENOID; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FIBROBLAST; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN CELL; HUMAN TISSUE; NORTHERN BLOTTING; OTITIS MEDIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOIDS; CLARITHROMYCIN; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOTOXINS; FIBROBLASTS; HAEMOPHILUS INFLUENZAE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-8; NF-KAPPA B; PROTEIN SYNTHESIS INHIBITORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; TRANS-ACTIVATION (GENETICS);

EID: 0042123644     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200308000-00021     Document Type: Article

References (43)

1. Marchisio P, Principi N, Passali D, et al. Epidemiology and treatment of otitis media with effusion in children in the first year of primary school. Acta Otolaryngol (Stockh) 1998;118:557-562.
2. Lim DJ, DeMaria TF, Bakaletz LO. Current concepts of pathogenesis of otitis media: a review. Acta Otolaryngol Suppl (Stockh) 1988;458:174-180.
3. Bernstein JM. Waldeyer's ring and otitis media: the nasopharyngeal tonsil and otitis media. Int J Pediatr Otorhinolaryngol 1999;49(Suppl 1):127-132.
4. Kurono Y, Shigemi H, Kodama S, Mogi G. The role of adenoids in nasopharyngeal colonization with nontypeable Haemophilus influenzae. Acta Otolaryngol (Stockh) 1995;523:147-149.
5. Lindberg K, Rynnel-Dagoo B, Sundqvist KG. Cytokines in nasopharyngeal secretions: evidence for defective IL-1 β production in children with recurrent episodes of acute otitis media. Clin Exp Immunol 1994;97:396-402.
6. Sheeran P, Jafri H, Carubelli C, et al. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr Infect Dis J 1999;18:115-122.
7. Khair OA, Davies RJ, Devalia JL. Bacterial-induced release of inflammatory mediators by bronchial epithelial cells. Eur Respir J 1996;9:1913-1922.
8. Miyanohara T, Ushikai M, Matsune S, et al. Effects of clarithromycin on cultured human nasal epithelial cells and fibroblasts. Laryngoscope 2000;110:126-131.
9. Bernstein JM, Ballow M, Xiang S, et al. Th1/Th2 cytokine profiles in the nasopharyngeal lymphoid tissues of children with recurrent otitis media. Ann Otol Rhinol Laryngol 1998;107:22-27.
10. Sakamoto N, Kurono Y, Suzuki M, et al. Immune responses of adenoidal lymphocytes specific to Haemophilus influenzae in the nasopharynx. Laryngoscope 1998;108:1036-1041.
11. Baggiolini M, Clark-Lewis I. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett 1992;307:97-101.
12. Maxwell KS, Fitzgerald JE, Burleson JA, et al. Interleukin-8 expression in otitis media. Laryngoscope 1994;104:989-995.
13. Nassif PS, Simpson SQ, Izzo AA, et al. Interleukin-8 concentration predicts the neutrophil count in middle ear effusion. Laryngoscope 1997;107:1223-1227.
14. Rhyoo C, Sanders SP, Leopold DA, et al. Sinus mucosal IL-8 gene expression in chronic rhinosinusitis. J Allergy Clin Immunol 1999;103:395-400.
15. Johnson M, Leonard G, Kreutzer DL. Murine model of interleukin-8-induced otitis media. Laryngoscope 1997;107:1405-1408.
16. Blackwell TS, Holden EP, Blackwell TR, et al. Cytokine-induced neutrophil chemoattractant mediates neutrophilic alveolitis in rats: association with nuclear factor kappa B activation. Am J Respir Cell Mol Biol 1994;11:464-472.
17. Na YJ, Jeon YJ, Suh JH, et al. Suppression of IL-8 gene expression by radicicol is mediated through the inhibition of ERK1/2 and p38 signaling and negative regulation of NF-kappa B and AP-1. Int Immunopharmacol 2001;1:1877-1887.
18. Kawakami K, Scheidereit C, Roeder RG. Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro. Proc Natl Acad Sci U S A 1988;85:4700-4704.
19. Kikuchi T, Hagiwara K, Honda Y, et al. Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-kappa B transcription factors. J Antimicrob Chemother 2002;49:745-755.
20. Abe S, Nakamura H, Inoue S, et al. Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells. Am J Respir Cell Mol Biol 2000;22:51-60.
21. Iino Y, Sugita K, Toriyama M, et al. Erythromycin therapy for otitis media with effusion in sinobronchial syndrome. Arch Otolaryngol Head Neck Surg 1993;119:648-651.
22. Cervin A. The anti-inflammatory effect of erythromycin and its derivatives, with special reference to nasal polyposis and chronic sinusitis. Acta Otolaryngol (Stockh) 2001;121:83-92.
23. Matsuzaki T, Itoh K, Katahira S, et al. Latent collagenase production by cells derived from nasal polyps in culture. Am J Rhinol 1994;8:241-246.
24. Wright SD, Ramos RA, Hermanowski-Vasatka A, et al. Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14. J Exp Med 1991;173:1281-1286.
25. Nonaka M, Pawankar R, Saji F, et al. Effect of roxithromycin on IL-8 synthesis and proliferation of nasal polyp fibroblasts. Acta Otolaryngol (Stockh) 1998;539(Suppl):71-75.
26. Jordana M, Schulman J, McSharry C, et al. Heterogeneous proliferative characteristics of human adult lung fibroblast lines and clonally derived fibroblasts from control and fibrotic tissue. Am Rev Respir Dis 1987;137:579-584.
27. s from small numbers of cells. Biotechniques 1989;7:1096-1103.
28. Rock FL, Hardiman G, Timans JC, et al. A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci U S A 1998;95:588-593.
29. Hoffmann JA, Kafatos FC, Janeway CA, et al. Phylogenetic perspectives in innate immunity. Science 1999;284:1313-1318.
30. Faure E, Thomas L, Xu H, et al. Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation. J Immunol 2001;166:2018-2024.
31. Collins T, Read MA, Neish AS, et al. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J 1995;9:899-909.
32. Chow JC, Young DW, Golenbock DT, et al. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999;274:10689-10692.
33. Willett DN, Rezaee RP, Billy JM, et al. Relationship of endotoxin to tumor necrosis factor-alpha and interleukin-1 beta in children with otitis media with effusion. Ann Otol Rhinol Laryngol 1998;107:28-33.
34. Patel JA, Jiang Z, Nakajima N, et al. Autocrine regulation of interleukin-8 by interleukin-1alpha in respiratory syncytial virus-infected pulmonary epithelial cells in vitro. Immunology 1998;95:501-506.
35. McClay JE. Resistant bacteria in the adenoids: a preliminary report. Arch Otolaryngol Head Neck Surg 2000;126:625-629.
36. Forsgren J, Samuelson A, Lindberg A, et al. Quantitative bacterial culture from adenoid lymphatic tissue with special reference to Haemophilus. Acta Otolaryngol (Stockh) 1993;113:668-672.
37. Forsgren J, Samuelson A, Borrelli S, et al. Persistence of nontypeable Haemophilus influenzae in adenoid macrophages: a putative colonization mechanism. Acta Otolaryngol 1996;116:766-773.
38. Kurono Y, Yamamoto M, Fujihashi K, et al. Nasal immunization induces Haemophilus influenzae-specific Th1 and Th2 responses with mucosal IgA and systemic igG antibodies for protective immunity. J Infect Dis 1999;180:122-132.
39. Nagai H, Shishido H, Yoneda R, et al. Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis. Respiration 1991;58:145-149.
40. Fujii T, Kadota J, Kawakami K, et al. Long-term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection. Thorax 1995;50:1246-1252.
41. Takizawa H, Desaki M, Ohtoshi T. Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells. Am J Respir Crit Care Med 1997;156:266-271.
42. Suzuki H, Shimomura A, Ikeda K. Inhibitory effect of macrolides on interleukin-8 secretion from cultured human nasal epithelial cells. Laryngoscope 1997;107:1661-1666.
43. Nonaka M, Pawankar R, Saji F, et al. Distinct expression of RANTES and GM-CSF by lipopolysaccharide in human nasal fibroblasts but not in other airway fibroblasts. Int Arch Allergy Immunol 1999;119:314-321.